Novo Nordisk is gradually ending production of human insulin pens, the drugmaker told Reuters, as it spends billions to ramp ...

Ahead of World Diabetes Day, Doctors Without Borders (MSF) called on pharmaceutical corporations Eli Lilly, Novo Nordisk, ...

Doctors Without Borders (MSF) is calling on Eli Lilly, Novo Nordisk and Sanofi to immediately reduce the price of insulin ...

The global insulin pens market size was valued at USD 7.46 billion in 2024 and is projected to reach from USD 8.05 billion in ...

Doctors Without Borders (MSF) and organisations representing people with diabetes picketed outside the offices of insulin ...

Europe is predicted to have the most significant market growth for smart insulin pens, reaching nearly USD 85.34 million by 2027, partly due to the high current utilization of such pen devices.

MSF calls for insulin manufacturers to provide $1 injection pens globally, emphasizing current high prices and limited access ...

Novo Nordisk has long supplied human insulin pens to the national health department. But last year it decided not to bid for ...

NovoPen ®, the first insulin pen injector, was introduced in 1985. This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes ...

Millions in South Africa face rising diabetes treatment costs and limited access to insulin pens, sparking protests.